{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:08:00Z","timestamp":1793660880534,"version":"4.5.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.MAZUMS.REC.1398.563"],"award-info":[{"award-number":["IR.MAZUMS.REC.1398.563"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Waterborne Parasitology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.fawpar.2025.e00269","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:14:58Z","timestamp":1748862898000},"page":"e00269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Design and immunological evaluation of a multi-epitope vaccine candidate against Toxoplasma gondii incorporating MIC13, GRA1, and SAG1 antigens in BALB\/c mice"],"prefix":"10.1016","volume":"40","author":[{"given":"Zahra","family":"Hosseininejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Daryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Fasihi-Ramandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Asgarian-Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooran","family":"Nayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Dodangeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Amouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Javidnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah","family":"Mayahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahabeddin","family":"Sarvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sargis A.","family":"Aghayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fawpar.2025.e00269_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104764","article-title":"Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB\/c mice","volume":"153","author":"Dodangeh","year":"2021","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.fawpar.2025.e00269_bb0010","first-page":"17","article-title":"T-cell immunity in human chronic toxoplasmosis","volume":"41","author":"El-Kady","year":"2011","journal-title":"J. Egypt. Soc. Parasitol."},{"issue":"3","key":"10.1016\/j.fawpar.2025.e00269_bb0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13205-020-2076-y","article-title":"Chitosan and chitosan nanoparticles as adjuvant in local Rift Valley Fever inactivated vaccine","volume":"10","author":"El-Sissi","year":"2020","journal-title":"3 Biotech."},{"issue":"6","key":"10.1016\/j.fawpar.2025.e00269_bb0020","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.4049\/jimmunol.148.6.1725","article-title":"IL-4 suppresses cytokine gene expression induced by IFN-gamma and\/or IL-2 in murine peritoneal macrophages","volume":"148","author":"Gautam","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.fawpar.2025.e00269_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trivac.2015.11.002","article-title":"Immunogenic multistage recombinant protein vaccine confers partial protection against experimental toxoplasmosis mimicking natural infection in murine model","volume":"5","author":"Gedik","year":"2016","journal-title":"Trials Vaccinol."},{"key":"10.1016\/j.fawpar.2025.e00269_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104079","article-title":"Structural predication and antigenic analysis of ROP16 protein utilizing immunoinformatics methods in order to identification of a vaccine against Toxoplasma gondii: an in silico approach","volume":"142","author":"Ghaffari","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.fawpar.2025.e00269_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2019.107733","article-title":"The course of infection with Toxoplasma gondii RH strain in mice pre-vaccinated with gamma irradiated tachyzoites","volume":"205","author":"Gomaa","year":"2019","journal-title":"Exp. Parasitol."},{"issue":"12","key":"10.1016\/j.fawpar.2025.e00269_bb0040","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1007\/s00436-015-4701-y","article-title":"Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins","volume":"114","author":"Grzybowski","year":"2015","journal-title":"Parasitol. Res."},{"issue":"24","key":"10.1016\/j.fawpar.2025.e00269_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.032","article-title":"A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis","volume":"42","author":"G\u00fcl","year":"2024","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.fawpar.2025.e00269_bb0050","first-page":"301","article-title":"In silico vaccine design and expression of the multi-component protein candidate against the Toxoplasma gondii parasite from MIC13, GRA1, and SAG1 antigens","volume":"18","author":"Hosseininejad","year":"2023","journal-title":"Iran. J. Parasitol."},{"issue":"5","key":"10.1016\/j.fawpar.2025.e00269_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/intimm\/dxae001","article-title":"The role of IFN-\u03b3-mediated host immune responses in monitoring and the elimination of Toxoplasma gondii infection","volume":"36","author":"Ihara","year":"2024","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.fawpar.2025.e00269_bb0060","first-page":"184","article-title":"Toxoplasma serology status and risk of miscarriage, a case-control study among women with a history of spontaneous abortion","volume":"13","author":"Kheirandish","year":"2019","journal-title":"Int. J. Fertil. Steril."},{"issue":"6","key":"10.1016\/j.fawpar.2025.e00269_bb0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3347\/kjp.2014.52.6.581","article-title":"Recent advances in Toxoplasma gondii immunotherapeutics","volume":"52","author":"Lim","year":"2014","journal-title":"Korean J. Parasitol."},{"key":"10.1016\/j.fawpar.2025.e00269_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.755792","article-title":"Protective effect against toxoplasmosis in BALB\/c mice vaccinated with recombinant Toxoplasma gondii MIF, CDPK3, and 14-3-3 protein cocktail vaccine","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.fawpar.2025.e00269_bb0075","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1186\/s12879-024-09807-x","article-title":"TgVax452, an epitope-based candidate vaccine targeting Toxoplasma gondii tachyzoite-specific SAG1-related sequence (SRS) proteins: immunoinformatics, structural simulations and experimental evidence-based approaches","volume":"24","author":"Majidiani","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.fawpar.2025.e00269_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11845-022-02998-9","article-title":"Toxoplasma gondii vaccine candidates: a concise review","volume":"192","author":"Mamaghani","year":"2023","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.fawpar.2025.e00269_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2022.108427","article-title":"Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice","volume":"244","author":"Nayeri","year":"2023","journal-title":"Exp. Parasitol."},{"issue":"6","key":"10.1016\/j.fawpar.2025.e00269_bb0090","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.drudis.2020.03.006","article-title":"Epitope-based vaccine design: a comprehensive overview of bioinformatics approaches","volume":"25","author":"Parvizpour","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.fawpar.2025.e00269_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117956","article-title":"Chemotherapy against Toxoplasma gondii: a bibliometric analysis of in vitro and mouse model studies (2015-2024)","volume":"186","author":"Reim\u00e3o","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fawpar.2025.e00269_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2019.107791","article-title":"Prevalence of Toxoplasma gondii parasite in captive Mexican jaguars determined by recombinant surface antigens (SAG1) and dense granular antigens (GRA1 and GRA7) in ELISA-based serodiagnosis","volume":"208","author":"Reynoso-Palomar","year":"2020","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.fawpar.2025.e00269_bb0105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12879-020-05220-2","article-title":"Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50V and determination of its protective efficacy against acute toxoplasmosis","volume":"20","author":"\u015eahar","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.fawpar.2025.e00269_bb0110","doi-asserted-by":"crossref","DOI":"10.1177\/03946320221078436","article-title":"Immune response against toxoplasmosis-some recent updates RH: Toxoplasma gondii immune response","volume":"36","author":"Sana","year":"2022","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"1","key":"10.1016\/j.fawpar.2025.e00269_bb0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13071-019-3362-6","article-title":"Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide","volume":"12","author":"S\u00e1nchez-L\u00f3pez","year":"2019","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.fawpar.2025.e00269_bb0120","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2019021","article-title":"Congenital toxoplasmosis among Iranian neonates: a systematic review and meta-analysis","volume":"41","author":"Sarvi","year":"2019","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.fawpar.2025.e00269_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.634610","article-title":"A protective and pathogenic role for complement during acute Toxoplasma gondii infection","volume":"11","author":"Sikorski","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.fawpar.2025.e00269_bb0130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00441-014-1879-8","article-title":"Activation of spleen cells by ArtinM may account for its immunomodulatory properties","volume":"357","author":"Silva","year":"2014","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.fawpar.2025.e00269_bb0135","doi-asserted-by":"crossref","first-page":"1209755","DOI":"10.3389\/fcimb.2023.1209755","article-title":"Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice","volume":"13","author":"Sun","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.fawpar.2025.e00269_bb0140","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1038\/s41467-018-06228-8","article-title":"A naturally protective epitope of limited variability as an influenza vaccine target","volume":"9","author":"Thompson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fawpar.2025.e00269_bb0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1756-3305-7-180","article-title":"Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii","volume":"7","author":"Wang","year":"2014","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.fawpar.2025.e00269_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/0471140864.ps0601s80","article-title":"Overview of the purification of recombinant proteins","volume":"80","author":"Wingfield","year":"2015","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.fawpar.2025.e00269_bb0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1051\/parasite\/2019050","article-title":"Evaluation of immune protection against Toxoplasma gondii infection in mice induced by a multi-antigenic DNA vaccine containing TgGRA24, TgGRA25 and TgMIC6","volume":"26","author":"Xu","year":"2019","journal-title":"Parasite"},{"issue":"4","key":"10.1016\/j.fawpar.2025.e00269_bb0160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/vaccines9040357","article-title":"Recombinant Toxoplasma gondii ribosomal protein P2 modulates the functions of murine macrophages in vitro and provides immunity against acute toxoplasmosis in vivo","volume":"9","author":"Yu","year":"2021","journal-title":"Vaccines"},{"issue":"31","key":"10.1016\/j.fawpar.2025.e00269_bb0165","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.vaccine.2013.05.040","article-title":"Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model","volume":"31","author":"Yuan","year":"2013","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.fawpar.2025.e00269_bb0170","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1016\/j.vaccine.2013.07.058","article-title":"The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice","volume":"31","author":"Zheng","year":"2013","journal-title":"Vaccine"}],"container-title":["Food and Waterborne Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405676625000162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405676625000162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:37:14Z","timestamp":1762623434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405676625000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"alternative-id":["S2405676625000162"],"URL":"https:\/\/doi.org\/10.1016\/j.fawpar.2025.e00269","relation":{},"ISSN":["2405-6766"],"issn-type":[{"value":"2405-6766","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and immunological evaluation of a multi-epitope vaccine candidate against Toxoplasma gondii incorporating MIC13, GRA1, and SAG1 antigens in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Food and Waterborne Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fawpar.2025.e00269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of International Association of Food and Waterborne Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"e00269"}}